Sustained reduction of intraocular pressure by supraciliary delivery of brimonidine-loaded poly(lactic acid) microspheres for the treatment of glaucoma
about
[Possibilities and limitations of eye drops for glaucoma therapy].Biocompatibility and Pharmacokinetic Analysis of an Intracameral Polycaprolactone Drug Delivery Implant for Glaucoma.Clearance Kinetics and Clearance Routes of Molecules From the Suprachoroidal Space After Microneedle InjectionThickness and Closure Kinetics of the Suprachoroidal Space Following Microneedle Injection of Liquid Formulations.The Pathway From Genes to Gene Therapy in Glaucoma: A Review of Possibilities for Using Genes as Glaucoma Drugs.Distribution of particles, small molecules and polymeric formulation excipients in the suprachoroidal space after microneedle injection.Long Term Glaucoma Drug Delivery Using a Topically Retained Gel/Microsphere Eye DropNew pharmacotherapy for the treatment of glaucoma.Long-term intraocular pressure reduction with intracameral polycaprolactone glaucoma devices that deliver a novel anti-glaucoma agent.Ocular drug delivery targeted by iontophoresis in the suprachoroidal space using a microneedle.Sustained Dorzolamide Release Prevents Axonal and Retinal Ganglion Cell Loss in a Rat Model of IOP-Glaucoma.Targeted Drug Delivery in the Suprachoroidal Space by Swollen Hydrogel Pushing.
P2860
Q36125697-920B09CF-C148-429F-8A79-BC68C18595C9Q37242149-501E45A3-9B37-4FE6-82A6-AA9DEF821B44Q37616184-0BA03086-5B59-4CF7-81C3-C1E31873CB84Q37616194-CFBCC6E5-6A40-43FA-B498-221C0C0980C6Q38761425-F6F89CB8-96C8-4738-866D-0C21F7CABB1BQ39289999-F27D1A0E-0B2A-4347-9642-A037F7A71F30Q41448579-23AD683A-E5D2-4373-9C1E-55E903A6C3C1Q46061291-DFDA33A8-B510-4BA3-9562-BBAA9AEEB9ADQ46885910-09EA0CE7-01CA-4E9F-B23E-D2BA1B3AC47FQ52673868-40E777EB-4313-4234-BEC8-FC7D6A94191DQ55038685-B650C845-9E3C-49A5-A596-6451EC35F270Q55315376-E0E5B9F2-CA6E-44C8-A093-24C5E2371EC2
P2860
Sustained reduction of intraocular pressure by supraciliary delivery of brimonidine-loaded poly(lactic acid) microspheres for the treatment of glaucoma
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Sustained reduction of intraoc ...... for the treatment of glaucoma
@ast
Sustained reduction of intraoc ...... for the treatment of glaucoma
@en
type
label
Sustained reduction of intraoc ...... for the treatment of glaucoma
@ast
Sustained reduction of intraoc ...... for the treatment of glaucoma
@en
prefLabel
Sustained reduction of intraoc ...... for the treatment of glaucoma
@ast
Sustained reduction of intraoc ...... for the treatment of glaucoma
@en
P2093
P2860
P1476
Sustained reduction of intraoc ...... for the treatment of glaucoma
@en
P2093
H E Grossniklaus
M R Prausnitz
S P Schwendeman
P2860
P356
10.1016/J.JCONREL.2016.02.041
P407
P577
2016-02-27T00:00:00Z